<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>COVID-19 &#8211; CapitalXchange</title>
	<atom:link href="https://capx.cooley.com/tag/covid-19/feed/" rel="self" type="application/rss+xml" />
	<link>https://capx.cooley.com</link>
	<description>Legal insight for the capital markets</description>
	<lastBuildDate>Thu, 17 Jun 2021 16:25:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://capx.cooley.com/wp-content/uploads/2025/08/cropped-pattern-wide-13-blue-32x32.png</url>
	<title>COVID-19 &#8211; CapitalXchange</title>
	<link>https://capx.cooley.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">238415165</site>	<item>
		<title>UK FCA Updates on COVID-19 Issues for Listed Companies</title>
		<link>https://capx.cooley.com/2020/06/09/uk-fca-updates-on-covid-19-issues-for-listed-companies/</link>
		
		<dc:creator><![CDATA[Cooley]]></dc:creator>
		<pubDate>Tue, 09 Jun 2020 15:51:33 +0000</pubDate>
				<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[FCA]]></category>
		<category><![CDATA[UK]]></category>
		<guid isPermaLink="false">https://capitalxchange.wpengine.com/?p=1537</guid>

					<description><![CDATA[On May 27, 2020, the Financial Conduct Authority in the UK published a newsletter outlining its continuing expectations of issuers in the UK on market conduct and transaction reporting issues. The FCA also published a Primary Market Bulletin setting out updates for issuers on temporary relief for the timing of the publication of half-yearly financial [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>On May 27, 2020, the Financial Conduct Authority in the UK published a newsletter outlining its continuing expectations of issuers in the UK on market conduct and transaction reporting issues. The FCA also published a Primary Market Bulletin setting out updates for issuers on temporary relief for the timing of the publication of half-yearly financial reports, going concern assessments and…</p>
<p><a href="https://capx.cooley.com/2020/06/09/uk-fca-updates-on-covid-19-issues-for-listed-companies/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1537</post-id>	</item>
		<item>
		<title>10 Key Considerations for IPOs During COVID-19</title>
		<link>https://capx.cooley.com/2020/05/05/10-key-considerations-for-ipos-during-covid-19/</link>
		
		<dc:creator><![CDATA[Cooley]]></dc:creator>
		<pubDate>Tue, 05 May 2020 18:26:10 +0000</pubDate>
				<category><![CDATA[Resource]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[IPO]]></category>
		<guid isPermaLink="false">https://capitalxchange.wpengine.com/?p=1479</guid>

					<description><![CDATA[Despite the COVID-19 pandemic and associated stock market difficulties, some IPOs are getting done. Prior to the pandemic, IPO timelines for the rest of 2020 were largely focused on navigating around the upcoming U.S. elections. The focus has now shifted to the duration and impact of the pandemic, and when for a particular company is [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>Despite the COVID-19 pandemic and associated stock market difficulties, some IPOs are getting done. Prior to the pandemic, IPO timelines for the rest of 2020 were largely focused on navigating around the upcoming U.S. elections. The focus has now shifted to the duration and impact of the pandemic, and when for a particular company is its business at a point where it can consider going public.</p>
<p><a href="https://capx.cooley.com/2020/05/05/10-key-considerations-for-ipos-during-covid-19/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1479</post-id>	</item>
		<item>
		<title>Cooley Supports Petition to SEC for E-Signatures</title>
		<link>https://capx.cooley.com/2020/05/04/cooley-supports-petition-to-sec-for-e-signatures/</link>
		
		<dc:creator><![CDATA[Cooley]]></dc:creator>
		<pubDate>Mon, 04 May 2020 15:34:00 +0000</pubDate>
				<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[SEC]]></category>
		<guid isPermaLink="false">https://capitalxchange.wpengine.com/?p=1469</guid>

					<description><![CDATA[Cooley, together with Wilson Sonsini Goodrich &#38; Rosati and Fenwick &#38; West, has submitted a petition to the SEC requesting a rule change to allow companies to use electronic signatures in their filings. Today, companies are required to sign many SEC filings, including registration statements filed in connection with IPOs, manually, as well as retain [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>Cooley, together with Wilson Sonsini Goodrich & Rosati and Fenwick & West, has submitted a petition to the SEC requesting a rule change to allow companies to use electronic signatures in their filings. Today, companies are required to sign many SEC filings, including registration statements filed in connection with IPOs, manually, as well as retain the originals of those manually signed copies for…</p>
<p><a href="https://capx.cooley.com/2020/05/04/cooley-supports-petition-to-sec-for-e-signatures/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1469</post-id>	</item>
		<item>
		<title>UK Pre-Emption Group Provides Temporary Additional Flexibility for Pre-Emption Disapplication Authorities</title>
		<link>https://capx.cooley.com/2020/04/02/uk-pre-emption-group-provides-temporary-additional-flexibility-for-pre-emption-disapplication-authorities/</link>
		
		<dc:creator><![CDATA[Cooley]]></dc:creator>
		<pubDate>Thu, 02 Apr 2020 14:30:00 +0000</pubDate>
				<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[UK]]></category>
		<guid isPermaLink="false">https://capitalxchange.wpengine.com/?p=1257</guid>

					<description><![CDATA[The UK Pre-Emption Group (PEG) issued a statement, published on April 1, 2020, regarding its expectations for non-pre-emptive issues by companies listed in the UK in the context of the coronavirus pandemic. Temporary increase The PEG recommends that investors, on a case-by-case basis, consider supporting non-pre-emptive issues by companies of up to 20% of their [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>The UK Pre-Emption Group (PEG) issued a statement, published on April 1, 2020, regarding its expectations for non-pre-emptive issues by companies listed in the UK in the context of the coronavirus pandemic. The PEG recommends that investors, on a case-by-case basis, consider supporting non-pre-emptive issues by companies of up to 20% of their issued share capital until September 30…</p>
<p><a href="https://capx.cooley.com/2020/04/02/uk-pre-emption-group-provides-temporary-additional-flexibility-for-pre-emption-disapplication-authorities/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1257</post-id>	</item>
		<item>
		<title>COVID-19 Updates for UK + European Capital Markets: FCA, FRC + PRA Joint Statement, AIM Guidance and ESMA Public Statement</title>
		<link>https://capx.cooley.com/2020/03/30/covid-19-updates-for-uk-european-capital-markets-fca-frc-pra-joint-statement-aim-guidance-and-esma-public-statement/</link>
		
		<dc:creator><![CDATA[Cooley]]></dc:creator>
		<pubDate>Mon, 30 Mar 2020 14:03:00 +0000</pubDate>
				<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[EU Market Abuse Regulation (MAR)]]></category>
		<category><![CDATA[European Union (EU)]]></category>
		<category><![CDATA[UK]]></category>
		<guid isPermaLink="false">https://capitalxchange.wpengine.com/?p=1260</guid>

					<description><![CDATA[In light of the COVID-19 pandemic, several key updates for UK and European capital markets have recently been released, focusing primarily on financial reporting, including a joint statement by the Financial Conduct Authority (FCA), Financial Reporting Council (FRC) and Prudential Regulation Authority (PRA), an Inside AIM publication by the London Stock Exchange (LSE) and a [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>In light of the COVID-19 pandemic, several key updates for UK and European capital markets have recently been released, focusing primarily on financial reporting, including a joint statement by the Financial Conduct Authority (FCA), Financial Reporting Council (FRC) and Prudential Regulation Authority (PRA), an Inside AIM publication by the London Stock Exchange (LSE) and a public statement from…</p>
<p><a href="https://capx.cooley.com/2020/03/30/covid-19-updates-for-uk-european-capital-markets-fca-frc-pra-joint-statement-aim-guidance-and-esma-public-statement/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1260</post-id>	</item>
		<item>
		<title>Practical Observations on Preparing Prospectuses Under the New Prospectus Regulation</title>
		<link>https://capx.cooley.com/2019/12/11/practical-observations-on-preparing-prospectuses-under-the-new-prospectus-regulation/</link>
		
		<dc:creator><![CDATA[Cooley]]></dc:creator>
		<pubDate>Wed, 11 Dec 2019 13:54:00 +0000</pubDate>
				<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[EU Market Abuse Regulation (MAR)]]></category>
		<category><![CDATA[European Union (EU)]]></category>
		<category><![CDATA[UK]]></category>
		<guid isPermaLink="false">https://capitalxchange.wpengine.com/?p=1223</guid>

					<description><![CDATA[On 21 July 2019 the new Prospectus Regulation (Regulation (EU) 2017/1129) (the &#8220;œNew Prospectus Regulation &#8220;) regime repealed and replaced the previous Prospectus Directive ( &#8220;œPD2 &#8220;) regime in all EU Member States. In this briefing we explore the impact of the New Prospective Regulation on issuers producing a prospectus in relation to equity shares [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>On 21 July 2019 the new Prospectus Regulation (Regulation (EU) 2017/1129) (the “œNew Prospectus Regulation “) regime repealed and replaced the previous Prospectus Directive ( “œPD2 “) regime in all EU Member States. In this briefing we explore the impact of the New Prospective Regulation on issuers producing a prospectus in relation to equity shares for review by the Financial Conduct…</p>
<p><a href="https://capx.cooley.com/2019/12/11/practical-observations-on-preparing-prospectuses-under-the-new-prospectus-regulation/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1223</post-id>	</item>
	</channel>
</rss>
